ICD-10 Coding for Acute Lymphocytic Leukemia(C83.0L, C91.0, C91.00)
Comprehensive guide to ICD-10 coding for acute lymphocytic leukemia, including remission and relapse documentation requirements.
Complete code families applicable to Acute Lymphocytic Leukemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C91.00 | Acute lymphoblastic leukemia not having achieved remission | Use for newly diagnosed or active ALL without remission. |
|
| C91.01 | Acute lymphoblastic leukemia, in remission | Use for ALL in complete remission. |
|
| C91.02 | Acute lymphoblastic leukemia, in relapse | Use for ALL in relapse after remission. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAcute Lymphocytic Leukemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Acute Lymphocytic Leukemia.
Omitting blast percentage
Impact
Clinical: Leads to misclassification of leukemia status., Regulatory: May result in non-compliance with coding standards., Financial: Affects reimbursement rates.
Mitigation
Always include blast percentage in documentation.
Incorrect remission coding
Impact
Reimbursement: Incorrect coding can affect DRG assignment., Compliance: May lead to audit triggers., Data Quality: Impacts accuracy of patient records.
Mitigation
Ensure documentation supports remission status with lab results.
Remission documentation
Impact
Inadequate documentation of remission status can trigger audits.
Mitigation
Ensure all remission statuses are supported by lab results.